Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
J Robot Surg. 2024 Jul 27;18(1):295. doi: 10.1007/s11701-024-01990-y.
To compare the difference in perioperative outcomes between standard pelvic lymph node dissection (sPLND) and extended pelvic lymph node dissection (ePLND) in robot-assisted radical cystectomy (RARC) and evaluate the survival outcomes. The clinical data were retrospectively collected from patients who underwent RARC between January 2016 and December 2020 in Nanjing Drum Hospital. The patients were divided into sPLND and ePLND group according to the extent of pelvic lymph node dissection. Finally, 80 pairs of patients obtained for two groups by propensity score matching (PSM) and their perioperative and survival outcomes were analyzed. The median number of dissected lymph nodes (LN) after PSM was 13 in sPLND group and 16 in ePLND group (P = 0.004). Perioperative complications were similar between 2 groups. After PSM, ePLND improved 5-year RFS and OS in all patients (85.74 vs. 61.94%, P = 0.004; 82.80 vs. 67.50%, P = 0.033), patients with ≥ T3 disease (73.66 vs. 23.86%; P = 0.007; 68.20 vs. 36.20%; P = 0.032) and patients with LN metastasis (67.70 vs. 7.33%; P = 0.004; 60.60 vs. 16.67%; P = 0.045) compared to sPLND. Extended PLND significantly increased lymph node yield without increasing complication and improved RFS and OS compared to sPLND.
比较机器人辅助根治性膀胱切除术(RARC)中标准盆腔淋巴结清扫术(sPLND)和扩展盆腔淋巴结清扫术(ePLND)在围手术期结果方面的差异,并评估生存结果。回顾性收集了 2016 年 1 月至 2020 年 12 月期间在南京鼓医院接受 RARC 的患者的临床资料。根据盆腔淋巴结清扫范围将患者分为 sPLND 和 ePLND 组。最后,通过倾向评分匹配(PSM)获得了 80 对患者,分析了他们的围手术期和生存结果。PSM 后 sPLND 组和 ePLND 组的中位淋巴结清扫数分别为 13 个和 16 个(P=0.004)。两组围手术期并发症相似。PSM 后,ePLND 提高了所有患者的 5 年 RFS 和 OS(85.74% vs. 61.94%,P=0.004;82.80% vs. 67.50%,P=0.033)、≥T3 疾病患者(73.66% vs. 23.86%,P=0.007;68.20% vs. 36.20%,P=0.032)和淋巴结转移患者(67.70% vs. 7.33%,P=0.004;60.60% vs. 16.67%,P=0.045)的 RFS 和 OS。与 sPLND 相比,ePLND 显著增加了淋巴结产量,而没有增加并发症,并改善了 RFS 和 OS。